Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
2.0400+0.1100 (+5.70%)
At close: 04:00PM EDT
1.9500 -0.09 (-4.41%)
After hours: 07:17PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Inverted Hammer

Inverted Hammer

Performance Outlook
Previous Close1.9300
Open1.9600
Bid2.0300 x 1400
Ask2.0300 x 2900
Day's Range1.9350 - 2.0700
52 Week Range1.9100 - 8.2700
Volume1,662,934
Avg. Volume1,254,700
Market Cap267.599M
Beta (5Y Monthly)1.46
PE Ratio (TTM)18.55
EPS (TTM)0.1100
Earnings DateMay 08, 2023 - May 12, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
-5% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ORGO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Organogenesis Holdings Inc.
    ORGO: What does Argus have to say about ORGO?ORGANOGENESIS HOLDINGS INC has an Investment Rating of SELL; a target price of $2.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    7 days agoArgus Research
View more
  • Insider Monkey

    Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2022 Earnings Call Transcript

    Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2022 Earnings Call Transcript March 1, 2023 Operator: Welcome, ladies and gentlemen to the Fourth Quarter and Fiscal Year 2022 Earnings Conference Call for Organogenesis Holdings Inc. Please note that this conference call is being recorded and that the recording will be available on the company’s website for replay shortly. […]

  • Motley Fool

    Why Shares of Unisys, Organogenesis, and Motorcar Parts of America Fell Today

    Shares of Unisys (NYSE: UIS), Organogenesis Holdings (NASDAQ: ORGO), and Motorcar Parts of America (NASDAQ: MPAA) fell today as all three stocks were removed from the S&P SmallCap 600 index as part of its quarterly rebalancing. Unisys closed the day down 14.1%, Organogenesis lost 18.5%, and Motorcar Parts of America gave up 12.2%. There are several reasons stocks fall when they're removed from a major index like the S&P SmallCap 600.

  • Simply Wall St.

    Organogenesis Holdings Full Year 2022 Earnings: Revenues Disappoint

    Organogenesis Holdings ( NASDAQ:ORGO ) Full Year 2022 Results Key Financial Results Revenue: US$450.9m (down 3.5% from...

Advertisement
Advertisement